Premium Healthcare Group (CAI:PHGC) EBITDA Margin %: 0.00% (As of . 20)


What is Premium Healthcare Group EBITDA Margin %?

Premium Healthcare Group CAI:PHGC -1.14% EBITDA Margin % is 0.00% as of . 20. Among 204 Medical Diagnostics & Research companies, Premium Healthcare Group ranks worse than 490195.59% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Premium Healthcare Group's EBITDA for the six months ended in . 20 was E£0.00 Mil. Premium Healthcare Group's Revenue for the six months ended in . 20 was E£0.00 Mil. Therefore, Premium Healthcare Group's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Premium Healthcare Group  (CAI:PHGC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Premium Healthcare Group EBITDA Margin % Related Terms

Premium Healthcare Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Premium Healthcare Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premium Healthcare Group EBITDA Margin % Chart

Premium Healthcare Group Annual Data
Trend
EBITDA Margin %

Premium Healthcare Group Semi-Annual Data
EBITDA Margin %

CAI:PHGC vs TMO, DHR, IDXX: EBITDA Margin % Comparison

For the Diagnostics & Research subindustry, Premium Healthcare Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Premium Healthcare Group EBITDA Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Premium Healthcare Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Premium Healthcare Group's EBITDA Margin % falls into.


Premium Healthcare Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Premium Healthcare Group's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Premium Healthcare Group's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Premium Healthcare Group (CAI:PHGC) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Premium Healthcare Group and its competitors. According to the industry distribution chart, Premium Healthcare Group ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry.
Is Premium Healthcare Group's EBITDA Margin % too high?
Premium Healthcare Group's current EBITDA Margin % is 0.00%. Based on the distribution chart, Premium Healthcare Group ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Premium Healthcare Group's EBITDA Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Premium Healthcare Group ranks #999999 out of 204 companies for EBITDA Margin %. This places Premium Healthcare Group in the lower half of its industry. The industry median EBITDA Margin % is 5.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Diagnostics & Research company?
The median EBITDA Margin % among Medical Diagnostics & Research companies is 5.20, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Premium Healthcare Group and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA Margin % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Premium Healthcare Group's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premium Healthcare Group stock overvalued right now?
Premium Healthcare Group (CAI:PHGC) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Premium Healthcare Group (CAI:PHGC), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premium Healthcare Group Business Description

Address 5 El Dakahlia, El Nasr Street, Port Said, EGY
Premium Healthcare Group Formerly City Lab is a company whose main purpose is to establish, operate and manage medical analysis laboratories, and import supplies and equipments, medical analysis laboratories.